CURRENTLY THERE ARE FOUR MANUFACTURING SITES FOR COMMERCIALOPE
1975
HXINCHU, TAIWAN
(1,638M2)
ANNUAL OUTPUT 300,000,000PCS
1997
SUZHOU, CHINA
(60,439 M2)
ANNUAL OUTPUT 1,200,000,000PCS
2007
KUNSHAN, CHINA (46,752 M2)
2013
HEFEI, CHINA
(96,765 M2)
ANNUAL OUTPUT 3,000,000,000PCS
ABOUT SHENGZOU Shengzou, with experience reference from Taiwan mother company, adopts modern experiments, effective management systems, and great quality control assurance system toward various products i
SHENGZOU GROUP ORGANIZATION CHART Shengzou, with experience reference from Taiwan mother company, adopts modern experiments, effective management systems, and great quality control assurance system toward various products in
MILESTONE/VISION Shengzou, with experience reference from Taiwan mother company, adopts modern experiments, effective management systems, and great quality control assurance system toward various products in
TECHNICAL CERTIFICATE Shengzou, with experience reference from Taiwan mother company, adopts modern experiments, effective management systems, and great quality control assurance system toward various products in
As the Chinese New Year approaches, the production of the COVID-19 vaccines is of great urgency, and its packaging needs to keep up with the pace in order to prevent the outbreak.On December 31th, 2020, the first COVID-19 vaccine was approved to be marketed in China with conditions. A number of other COVID-19 vaccine have also been carried out phase III clinical trials in overseas countries, and the research and development of the vaccine has entered the sprint phase and is ready for mass production.
